Back to calendar
Braveheart Bio, Inc. (BRVE) Earnings
BRVE reports earnings on Tuesday, September 8, 2026
earnings report
September 8, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.44
Actual EPS: $-2.51
EPS surprise: -193.45%
Company overview
Market Cap$2.5B
PriceUSD 27.54
52-week high32.00
52-week low24.30
SectorHealth Technology
IndustryPharmaceuticals: Major